SDSU Heart Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Pharmacol Res. 2018 Jan;127:110-115. doi: 10.1016/j.phrs.2017.06.007. Epub 2017 Jun 13.
Stem cell mediated cardiac repair is an exciting and controversial area of cardiovascular research that holds the potential to produce novel, revolutionary therapies for the treatment of heart disease. Extensive investigation to define cell types contributing to cardiac formation, homeostasis and regeneration has produced several candidates, including adult cardiac c-Kit+ expressing stem and progenitor cells that have even been employed in a Phase I clinical trial demonstrating safety and feasibility of this therapeutic approach. However, the field of cardiac cell based therapy remains deeply divided due to strong disagreement among researchers and clinicians over which cell types, if any, are the best candidates for these applications. Research models that identify and define specific cardiac cells that effectively contribute to heart repair are urgently needed to resolve this debate. In this review, current c-Kit reporter models are discussed with respect to myocardial c-Kit cell biology and function, and future designs imagined to better represent endogenous myocardial c-Kit expression.
干细胞介导的心脏修复是心血管研究中一个令人兴奋且备受争议的领域,它有可能为心脏病的治疗带来新的、革命性的疗法。广泛的研究旨在确定参与心脏形成、稳态和再生的细胞类型,已经产生了几种候选细胞,包括成年心脏 c-Kit+表达的干细胞和祖细胞,这些细胞甚至已经被应用于 I 期临床试验,证明了这种治疗方法的安全性和可行性。然而,由于研究人员和临床医生在哪些细胞类型(如果有的话)最适合这些应用方面存在强烈分歧,心脏细胞治疗领域仍然存在严重分歧。迫切需要能够识别和定义有效促进心脏修复的特定心脏细胞的研究模型来解决这一争议。在这篇综述中,讨论了当前的 c-Kit 报告基因模型,以及它们与心肌 c-Kit 细胞生物学和功能的关系,并设想了未来的设计,以更好地代表内源性心肌 c-Kit 的表达。